# Special session ST03
## Organizers: Olivier Gevaert (Stanford), , William Hsu (UCLA), Arvind Rao (University of Michigan)

### References
(In order of appearance)

**[Sonn et al, 2017]** Sonn GA, Fan RE, Ghanouni P, Wang NN, Brooks JD, Loening AM, Daniel BL, To’o KJ, Thong AE, Leppert JT. Prostate magnetic resonance imaging interpretation varies substantially across radiologists. European urology focus. 2019 Jul 1;5(4):592-9. [Crossref](https://doi.org/10.1016/j.euf.2017.11.010)

**[Singh et al, 2021]** Singh G, Manjila S, Sakla N, True A, Wardeh AH, Beig N, Vaysberg A, Matthews J, Prasanna P, Spektor V. Radiomics and radiogenomics in gliomas: a contemporary update. British Journal of Cancer. 2021 May 6:1-7. [Crossref]([https://doi.org/10.1038/s41416-021-01387-w](https://doi.org/10.1038/s41416-021-01387-w))

**[McGarry et al, 2018]** McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD. Radio-pathomic maps of epithelium and lumen density predict the location of high-grade prostate cancer. International Journal of Radiation Oncology* Biology* Physics. 2018 Aug 1;101(5):1179-87. [Crossref](https://doi.org/10.1016/j.ijrobp.2018.04.044)

**[Khorrami et al, 2019]** Khorrami M, Khunger M, Zagouras A, Patil P, Thawani R, Bera K, Rajiah P, Fu P, Velcheti V, Madabhushi A. Combination of peri-and intratumoral radiomic features on baseline CT scans predicts response to chemotherapy in lung adenocarcinoma. Radiology: Artificial Intelligence. 2019 Mar 20;1(2):180012. [Crossref](https://doi.org/10.1148/ryai.2019180012)

**[Zwanenburg, 2020]** Zwanenburg A, Vallières M, Abdalah MA, Aerts HJ, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, Bogowicz M. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020 May;295(2):328-38. [Crossref](https://doi.org/10.1148/radiol.2020191145)
